Akums Drugs (India) Price Prediction
| AKUMS Stock | 491.50 3.35 0.68% |
Momentum 39
Sell Extended
Oversold | Overbought |
Quarterly Revenue Growth 0.051 |
Using Akums Drugs hype-based prediction, you can estimate the value of Akums Drugs and from the perspective of Akums Drugs response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Akums Drugs to buy its stock at a price that has no basis in reality. In that case, they are not buying Akums because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Akums Drugs after-hype prediction price | INR 489.23 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Akums |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akums Drugs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Akums Drugs After-Hype Price Prediction Density Analysis
As far as predicting the price of Akums Drugs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Akums Drugs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Akums Drugs, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Akums Drugs Estimiated After-Hype Price Volatility
In the context of predicting Akums Drugs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Akums Drugs' historical news coverage. Akums Drugs' after-hype downside and upside margins for the prediction period are 486.65 and 491.81, respectively. We have considered Akums Drugs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Akums Drugs is very steady at this time. Analysis and calculation of next after-hype price of Akums Drugs is based on 3 months time horizon.
Akums Drugs Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Akums Drugs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Akums Drugs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Akums Drugs, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.30 | 2.58 | 2.27 | 3.87 | 2 Events / Month | 1 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
491.50 | 489.23 | 0.46 |
|
Akums Drugs Hype Timeline
Akums Drugs is presently traded for 491.50on National Stock Exchange of India of India. The entity has historical hype elasticity of -2.27, and average elasticity to hype of competition of -3.87. Akums is anticipated to decline in value after the next headline, with the price expected to drop to 489.23. The average volatility of media hype impact on the company price is about 34.17%. The price decline on the next news is expected to be -0.46%, whereas the daily expected return is presently at -0.3%. The volatility of related hype on Akums Drugs is about 20.0%, with the expected price after the next announcement by competition of 487.63. About 83.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Assuming the 90 days trading horizon the next anticipated press release will be in a few days. Check out Akums Drugs Basic Forecasting Models to cross-verify your projections.Akums Drugs Related Hype Analysis
Having access to credible news sources related to Akums Drugs' direct competition is more important than ever and may enhance your ability to predict Akums Drugs' future price movements. Getting to know how Akums Drugs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Akums Drugs may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BIKAJI | Bikaji Foods International | (21.85) | 4 per month | 0.00 | (0.05) | 4.77 | (4.18) | 19.56 | |
| COMPUSOFT | Compucom Software Limited | 0.49 | 3 per month | 0.00 | (0.18) | 4.08 | (4.59) | 13.51 | |
| SONATSOFTW | Sonata Software Limited | (25.15) | 2 per month | 0.00 | (0.16) | 4.72 | (4.80) | 20.82 | |
| NEWGEN | Newgen Software Technologies | (33.75) | 5 per month | 0.00 | (0.02) | 5.64 | (6.64) | 27.66 | |
| RSSOFTWARE | R S Software | (3.06) | 3 per month | 0.00 | (0.53) | 4.04 | (5.01) | 15.25 | |
| TERASOFT | Tera Software Limited | 10.20 | 4 per month | 0.00 | (0.04) | 5.00 | (4.50) | 10.00 | |
| BFUTILITIE | BF Utilities Limited | (17.20) | 2 per month | 0.00 | (0.15) | 5.00 | (5.00) | 12.34 |
Akums Drugs Additional Predictive Modules
Most predictive techniques to examine Akums price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Akums using various technical indicators. When you analyze Akums charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Akums Drugs Predictive Indicators
The successful prediction of Akums Drugs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Akums Drugs and, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Akums Drugs based on analysis of Akums Drugs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Akums Drugs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Akums Drugs's related companies.
Story Coverage note for Akums Drugs
The number of cover stories for Akums Drugs depends on current market conditions and Akums Drugs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Akums Drugs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Akums Drugs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.